Literature DB >> 32635970

Dragendorff's reagent: Historical perspectives and current status of a versatile reagent introduced over 150 years ago at the University of Dorpat, Tartu, Estonia.

A Raal1, A Meos2, T Hinrikus2, J Heinämäki2, E Romāne3, V Gudienė4, V Jak Tas5, O Koshovyi6, A Kovaleva6, C Fursenco7, T Chiru7, H T Nguyen8.   

Abstract

The well-known Dragendorff's reagent (DR) was introduced by an Estonian-German Professor Johann Georg Noel Dragendorff (1836-1898) in the middle of the 19th century (1866). Dragendorff, who was a full-time professor in pharmacy at the university of Dorpat (Tartu) used his reagent originally for the rapid screening of herbal products to find traces of alkaloids. DR is a solution of potassium bismuth iodide composing of basic bismuth nitrate (Bi(NO₃)₃), tartaric acid, and potassium iodide (KI), and when contact with alkaloids DR produces an orange or orange red precipitate. In this review article, we make a short historical overview on the biography and scientific research work of Professor Dragendorff at the University of Dorpat. The chemistry, method of preparation, mechanism of action, and practical uses of DR in various disciplines in various European countries including the Baltic countries (Estonia, Latvia, Lithuania), Finland, Ukraine, Moldova, and in Asia (Vietnam), are also discussed. Over several decades, DR and its modifications have found uses in many new applications and disciplines, and a number of commercial DRs are also currently available on the market. Today, DR is used for example in the production of surfactants, where non-ionic surfactant is precipitated in water solution with modified DR (KBiI₄+BaCl₂+glacial acetic acid). Total six different potassium iodobismuthate (DR) solutions are also presented in the European Pharmacopoeia. In conclusion, DR (after more than 150 years of its invention in Estonia) has still an important role in pharmaceutical and related sciences all over the world.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32635970     DOI: 10.1691/ph.2020.0438

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  The Biotin-Avidin Interaction in Biotinylated Gold Nanoparticles and the Modulation of Their Aggregation.

Authors:  Yanchao Lyu; Álvaro Martínez; Federica D'Incà; Fabrizio Mancin; Paolo Scrimin
Journal:  Nanomaterials (Basel)       Date:  2021-06-13       Impact factor: 5.076

2.  In Vitro Inhibitory and Proliferative Cellular Effects of Different Extracts of Struthanthus quercicola: A Preliminary Study.

Authors:  Luz Eugenia Alcántara-Quintana; Carely Arjona-Ruiz; Denisse de Loera; Rubí Gamboa-León; Yolanda Terán-Figueroa
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-13       Impact factor: 2.650

3.  Arctostaphylos uva-ursi L. leaves extract and its modified cysteine preparation for the management of insulin resistance: chemical analysis and bioactivity.

Authors:  Ganna Kravchenko; Oksana Krasilnikova; Ain Raal; Matar Mazen; Natalia Chaika; Igor Kireyev; Andriy Grytsyk; Oleh Koshovyi
Journal:  Nat Prod Bioprospect       Date:  2022-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.